BN

Bhagvanjibhai Nathubhai Limbasiya

Active Director Director DIN 07493355
DIN 07493355 First appointment Aug 2016 Primary industry Manufacturing
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhagvanjibhai Nathubhai Limbasiya

Data last updated:

Bhagvanjibhai Nathubhai Limbasiya is a Director at Medvita Pharmaceuticals Private Limited (since 2016). The company operates in Manufacturing.

DIN 07493355
Primary Designation Director
Industry Manufacturing
First Appointment 11 Aug 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Aug 20162016Active

Board colleagues of Bhagvanjibhai Nathubhai Limbasiya

Directorship timeline

Open interactive timeline →
Medvita Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bhagvanjibhai Nathubhai Limbasiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhagvanjibhai Nathubhai Limbasiya

Bhagvanjibhai Nathubhai Limbasiya currently holds 1 directorship: Medvita Pharmaceuticals Private Limited (Director, since 11 Aug 2016).

Bhagvanjibhai Nathubhai Limbasiya was first appointed on 11 Aug 2016 as Director at Medvita Pharmaceuticals Private Limited.

The current boards of Bhagvanjibhai Nathubhai Limbasiya's companies include Maulik Mathurbhai Chovatiya (Medvita Pharmaceuticals Private Limited), Siddharth Dudhagra (Medvita Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available